COHANCE.NS Cohance Lifesciences Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 272982 | 134795 | 49.38% |
| 2026-08-27 | 308834 | 122117 | 39.54% |
| 2026-08-26 | 1018072 | 366992 | 36.05% |
| 2026-08-25 | 635089 | 295342 | 46.50% |
| 2026-08-24 | 909426 | 395610 | 43.50% |
| 2026-08-21 | 1638869 | 625779 | 38.18% |
| 2026-08-20 | 6561470 | 1364462 | 20.80% |
| 2026-08-19 | 282289 | 123884 | 43.89% |
| 2026-08-18 | 1507812 | 431553 | 28.62% |
| 2026-08-17 | 1708901 | 506502 | 29.64% |
| 2026-08-14 | 388718 | 198405 | 51.04% |
| 2026-08-13 | 605174 | 291523 | 48.17% |
| 2026-08-12 | 517907 | 279758 | 54.02% |
| 2026-08-11 | 2268116 | 717244 | 31.62% |
| 2026-08-10 | 1368704 | 695912 | 50.84% |
| 2026-08-07 | 1985052 | 1505136 | 75.82% |
| 2026-08-06 | 6018027 | 1358172 | 22.57% |
| 2026-08-05 | 365514 | 194894 | 53.32% |
| 2026-08-04 | 247065 | 128555 | 52.03% |
| 2026-08-03 | 312974 | 157041 | 50.18% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers COHANCE.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 19 Sep 2025 | Jusmiral Holdings Limited | Promoters | Sell | - | 34148000 | 30938088000 | 24.15% | XBRL |
| 12 May 2025 | Dr. Venkata Naga Kali Vara Prasada Raju Vetukuri | Director | Buy | Scheme of Amalgamation/Merger/Demerger/Arrangement | 713259 | 713259 | 0.19% | XBRL |
| 12 May 2025 | Jusmiral Holdings Limited | Promoters | Buy | Scheme of Amalgamation/Merger/Demerger/Arrangement | 126538578 | 126538578 | 33.08% | XBRL |
| 30 Sep 2023 | JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED | Promoters | Sell | Off Market | 127537043 | 63130836285 | 9.90% | XBRL |
| 14 Aug 2023 | PADMAJA J.A.S | Immediate relative | Sell | Market Sale | 28000 | 14049630 | 0.00% | XBRL |
| 17 Feb 2023 | PADMAJA J.A.S | Immediate relative | Sell | Market Sale | 7000 | 3375726 | 0.01% | XBRL |
| 02 Sep 2020 | PADMAJA J.A.S | Immediate relative | Buy | Market Purchase | 5000 | 3203198 | 0.01% | XBRL |
| 31 Aug 2020 | PADMAJA J.A.S | Immediate relative | Buy | Market Purchase | 2500 | 1720386 | 0.01% | XBRL |
| 27 Aug 2020 | PADMAJA J.A.S | Immediate relative | Buy | Market Purchase | 5000 | 3514022 | 0.01% | XBRL |
| 24 Aug 2020 | PADMAJA J.A.S | Immediate relative | Buy | Market Purchase | 5000 | 3428711 | 0.00% | XBRL |
| 04 Jul 2020 | PADMA KUMAR R | Employees/Designated Employees | Buy | Market Purchase | 10000 | 4703067 | 0.10% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers COHANCE.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
Eroding
ROCE Trajectory
Earnings Quality
Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q2 FY2023-24 | Q3 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹231.05 Cr. | ₹219.82 Cr. | ₹230.69 Cr. | ₹257.72 Cr. | ₹307.15 Cr. | ₹402.02 Cr. | ₹549.31 Cr. | ₹544.55 Cr. | ₹619.12 Cr. | ₹422.26 Cr. | RevenueFromOperations |
| Net Profit | ₹79.56 Cr. | ₹46.75 Cr. | ₹60.76 Cr. | ₹82.21 Cr. incl. minority ₹81.98 Cr. | ₹82.88 Cr. incl. minority ₹83.29 Cr. | ₹42.01 Cr. incl. minority ₹38.73 Cr. | ₹48.88 Cr. incl. minority ₹46.40 Cr. | ₹36.72 Cr. incl. minority ₹29.02 Cr. | ₹19.55 Cr. incl. minority ₹8.31 Cr. | ₹-24.12 Cr. incl. minority ₹-45.19 Cr. | ProfitLossForPeriod |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers COHANCE.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 1792300000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 382600000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 17962600000.0 |
| CurrentLiabilities | 6459300000.0 |
| EquityAttributableToOwnersOfParent | 39112900000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 1696700000.0 |